In the rapidly evolving world of modern medicine, it is important that the transition of basic scientific discoveries into new medical treatments takes place with both precision and speed.
NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs – which I’ve discussed a few times on the blog before – are a key part of NIH’s translational research portfolio. ….
Tom Kalil is Deputy Director for Technology and Innovation in the White House Office of Science and Technology Policy (OSTP). — We are delighted to announce a new collaboration between the National Institutes of Health (NIH) and the National Science Foundation (NSF) to empower entrepreneurial scientists and advance the Lab-to-Market priorities set forth in the President’s Management Agenda. The Federal government invests over $130 billion on research and development (R&D) each year, and the President’s 2015 budget supports a sustained commitment to accelerate the transfer of promising Federally-funded technologies from the laboratory to the commercial marketplace.
5 Comments
Since the last time I’ve written about our small business research programs, there have been a lot of important changes as a result of the Congressional reauthorization that mandated Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding requirements through fiscal year 2017. …. We have been working diligently alongside the Small Business Administration to put these changes into effect for NIH, as described on the SBIR/STTR Reauthorization Act of 2011: NIH Implementation of Key Changes website. As the 2014 HHS-wide SBIR and STTR Omnibus solicitations were announced last week, I thought it would be good to highlight some of these important reforms. ….
2 Comments
0 Comments